Reidy Christopher R 4

What Happened

• Christopher R. Reidy, a non-employee director of Encompass Health Corporation (EHC), reported acquisitions on April 15–16, 2026. He was credited 19 restricted stock units (RSUs) on April 15 (reported at $0.00) and acquired 334 shares on April 16 at a weighted average price of $106.48, for a reported cash value of $35,564. These transactions are awards/purchases, i.e., acquisitions rather than sales.

Key Details

• Transaction dates and prices:
  • 2026-04-15: Award (RSUs) — 19 shares, $0.00 reported (see F1).
  • 2026-04-16: Acquisition (market purchases via plan) — 334 shares, weighted avg $106.48, total $35,564 (see F2 & F3).
• Shares owned after transaction: Not provided in the summary data supplied.
• Notable footnotes:
  • F1: 19 RSUs credited as the dividend reinvestment award tied to the $0.19 per-share dividend paid April 15, 2026 (closing price $105.24 used to calculate RSUs).
  • F2: 334 shares were purchased by the Directors Deferred Stock Investment Plan using deferred director fees and reinvested dividends.
  • F3: $106.48 is a weighted average; purchases occurred at prices from $106.21 to $106.48. The reporting person can supply the per-trade breakdown on request.
• Filing timeliness: Report filed April 16, 2026 for transactions through April 15, 2026 — appears timely.

Context

• These were acquisitions: a dividend-credit RSU award and purchases made under a director deferral plan (i.e., the company-administered plan used to buy shares with deferred fees and reinvested dividends). Awards and purchases by insiders are factual disclosures and do not, by themselves, indicate motivation.